Avana Health
Lexington, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Avana Health
Sign up to see every warm intro you have to Avana Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avana Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intrauterine delivery platform for treating abnormal uterine bleeding and postpartum hemorrhage.
Founders & leadership
PP

Peter PacultCo-Founder and CEOPeter Pacult co-founded Avana Health, which develops an intrauterine delivery platform for treating abnormal uterine bleeding and postpartum hemorrhage, and previously spent 11 years in finance at a family business, advancing to Vice President and Director of Research and Development, before joining a pharmaceutical startup where he grew operations to 30 staff members and oversaw $35 million in multi-year projects. He has also co-founded a company in media and holds expertise in strategic planning, team building, and program management.
JM
John MoreheadExecutive
Board
HS

Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2022–2025
▶$2.8MraisedDec 2025 · 29 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedDec 2025 · 29 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter PacultExecutive Officer, Director
- Howard SettleExecutive Officer, Director
- John MoreheadExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.8M
- Minimum investment
- $50K
- Proceeds to insiders
- $600K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$120KraisedAug 2023 · 1 investors · Other Health CareRule 506(b)
▶$120KraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Howard SettleExecutive Officer, Director
- Peter PacultExecutive Officer, Director
- John MoreheadExecutive Officer, Director
- Offering amount
- $900K
- Amount sold
- $120K
- Minimum investment
- $30K
- Proceeds to insiders
- $12K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$127.5KraisedNov 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$127.5KraisedNov 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John MoreheadExecutive Officer, Director
- Peter PacultExecutive Officer, Director
- Howard SettleExecutive Officer, Director
- Offering amount
- $510K
- Amount sold
- $127.5K
- Minimum investment
- $25.5K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Avana Health do?
- Intrauterine delivery platform for treating abnormal uterine bleeding and postpartum hemorrhage.
- Who are Avana Health's investors?
- Avana Health's investors include Keyhorse Capital.
- How much funding has Avana Health raised?
- Avana Health has disclosed $3M raised across 3 rounds.
- Where is Avana Health headquartered?
- Avana Health is headquartered in Lexington, US.
